CDKN2A and acute lymphoblastic leukemia: Variant allele of rs3731249 induced amino acid change in p16INK4A, protein product of CDKN2A, and reduced the tumor suppression effect of p16INK4A, suggesting rs3731249 act as a causal variant for ALL susceptibility.